2098 Assessment of pharmacokinetic (PK) interaction between cetuximab (CTX) and capecitabine (CCB) or oxaliplatin (OX) in metastatic colorectal cancer (mCRC) patients (pts) (AGMT_CAPECET_PK). (September 2015) - Schreiber, V.; Kitzmueller, M.; Buchner, P.; Weissenboeck, N.; Lichtneckert, M.; Greil, R.; Geiler, H.; Czejka, M.; Dittrich, C.